Jack Steele

→

People

Jack Steele

Investment Committee
Jack Steele

Jack is a member of the Investment Committee at Main Sequence, representing CSIRO and driving investment for early-stage companies linked to the Australian tech sector. He is an executive in the government engagement team at CSIRO, bringing experience in science management, commercial management, governance and the development of policy for translating science. Jack was the architect of CSIRO’s establishment of Main Sequence as an early-stage venture capital fund for translating research from the university sector and CSIRO, and from 2015 to 2023 he led the CSIRO team that built the fund.

Jack’s research career from 1980 to 2000 spanned metastatic cell spread, the cell biology of nerve development, and biomaterials for cardiovascular and ophthalmic applications. From 2000, he held CSIRO corporate roles building governance processes for commercial activities and leading complex commercial and IP transactions, including startups and venture capital fund investments. Jack is a Pro-Chancellor and member of the Council of the University of Technology Sydney.

Jack holds a BSc (Hons) and a PhD in Biochemistry from the University of Western Australia and is a Fellow of the Australian Academy of Technology and Engineering (FTSE).

Portfolio

No items found.

Writing

No items found.
For founders

Building for the systems that matter? Pitch us.

We back founders turning breakthrough science into category-defining companies.

Submit your pitch
For investors

Invest with Main Sequence

Access Australia's deep tech frontier alongside us.

Investor enquiries